NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) Inks Agreement to Acquire Novo Formulations, Broadens Alternative Medicine Portfolio
Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the expansion of its vertically integrated, alternative medicine product portfolio with the addition of new proprietary intellectual property (“IP”). SHRM recently entered into a definitive agreement, signed March 18, 2020, to acquire Novo Formulations Ltd. (“Novoformulations”), a specialty biotechnology company focused on developing novel and innovative delivery systems for the pharmaceutical and nutraceutical industries. Per the terms of the agreement, Champignon will acquire 100% of the issued and outstanding shares of Novoformulations for a total consideration of 12.5 million common shares in the capital…







